Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 5

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Trends in the prevalence of cardiometabolic diseases in US adults with newly diagnosed and undiagnosed diabetes, 1988–2020

Shi, Shuxiao, Zhou, Feng, Shen, Jie · 2025 · Public Health

Abstract

OBJECTIVES Early detection and timely management of cardiometabolic diseases (CMDs) in diabetes are critical for preventing vascular complications and premature mortality. However, the prevalence of CMDs over time in adults with newly diagnosed and undiagnosed diabetes is unclear. STUDY DESIGN Cross-sectional study. METHODS Included were US adults aged ≥20 years with newly diagnosed diabetes and undiagnosed diabetes using data from the National Health and Nutrition Examination Survey in 1988-2020. CMDs included obesity, severe obesity, dyslipidemia, hypertension, metabolic dysfunction-associated fatty liver disease (MAFLD), chronic kidney disease (CKD), and cardiovascular disease (CVD). Poisson regressions were used to assess trends in the prevalence of CMDs and to compare the prevalence between newly diagnosed and undiagnosed diabetes. RESULTS For both diabetes phenotypes in 1988-2020, the prevalence of obesity and severe obesity increased and CKD decreased (P < 0.05). The prevalence of dyslipidemia decreased and MAFLD increased in undiagnosed diabetes (P < 0.05). In 2011-2020, the prevalence of CMDs ranged from 14.3 % for CVD to 78.6 % for dyslipidemia. No significant difference in the prevalence of all CMDs between the 2 diabetes phenotypes was observed. CONCLUSIONS The prevalence of CMDs remained high in US adults with newly diagnosed and undiagnosed diabetes during the previous 3 decades, with no significant difference in the prevalence between the 2 diabetes phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.puhe.2024.12.041

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 24

  1. Rawshani, 2016, Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes, JAMA Intern Med, 176, 1146, 10.1001/jamainternmed.2016.2940 · DOI
  2. Jelinek, 2017, Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates, BMJ Open Diabetes Res Care, 5, 10.1136/bmjdrc-2017-000427 · DOI
  3. Wang, 2021, Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018, JAMA, 326, 1, 10.1001/jama.2021.9883 · DOI · Paper page
  4. Ogurtsova, 2022, IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021, Diabetes Res Clin Pract, 183, 10.1016/j.diabres.2021.109118 · DOI · Paper page
  5. Bjarkø, 2022, Undiagnosed diabetes: prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway, Diabet Med, 39, 10.1111/dme.14829 · DOI
  6. Association, 2016, 2. Classification and diagnosis of diabetes, Diabetes Care, 40, S11, 10.2337/dc17-S005 · DOI · Paper page
  7. Steinberger, 2005, Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents, Int J Obes, 29, 1346, 10.1038/sj.ijo.0803026 · DOI · Paper page
  8. Whelton, 2017, Hypertension, 71, 1269, 10.1161/HYP.0000000000000066 · DOI · Paper page
  9. Mooradian, 2009, Dyslipidemia in type 2 diabetes mellitus, Nat Rev Endocrinol, 5, 150, 10.1038/ncpendmet1066 · DOI · Paper page
  10. Zhou, 2022, Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention, Cardiovasc Diabetol, 21, 270, 10.1186/s12933-022-01697-0 · DOI · Paper page
  11. Rovin, 2021, KDIGO 2021 clinical practice guideline for the management of glomerular diseases, Kidney Int, 100, S1, 10.1016/j.kint.2021.05.021 · DOI · Paper page
  12. Goff, 2013, ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American heart association task force on practice guidelines, J Am Coll Cardiol, 63, 2935, 10.1016/j.jacc.2013.11.005 · DOI · Paper page
  13. Wang, 2021, Age at diagnosis of diabetes by race and ethnicity in the United States from 2011 to 2018, JAMA Intern Med, 181, 1537, 10.1001/jamainternmed.2021.4945 · DOI
  14. Dorans, 2018, Trends in prevalence and control of hypertension according to the 2017 American College of Cardiology/American heart association (ACC/AHA) guideline, J Am Heart Assoc, 7, 10.1161/JAHA.118.008888 · DOI · Paper page
  15. Flegal, 1998, Overweight and obesity in the United States: prevalence and trends, 1960-1994, Int J Obes Relat Metab Disord, 22, 39, 10.1038/sj.ijo.0800541 · DOI · Paper page
  16. Yang, 2022, Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999-2018, BMC Geriatr, 22, 979, 10.1186/s12877-022-03672-6 · DOI
  17. Adejumo, 2019, Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States, Ann Gastroenterol, 32, 504
  18. Esser, 2015, Inflammatory markers and cardiometabolic diseases, Acta Clin Belg, 70, 193, 10.1179/2295333715Y.0000000004 · DOI
  19. 2022, Cardiovascular disease and risk management: standards of medical care in diabetes-2022, Diabetes Care, 45, S144, 10.2337/dc22-S010 · DOI · Paper page
  20. Fisher-Hoch, 2015, Undiagnosed diabetes and pre-diabetes in health disparities, PLoS One, 10, 10.1371/journal.pone.0133135 · DOI
  21. Young, 2024, Determinants of health and mortality in undiagnosed diabetes: a nationally representative US adult, 2011-2020, Diabetes Res Clin Pract, 210
  22. Deboer, 2013, Ethnic differences in the link between insulin resistance and elevated ALT, Pediatrics, 132, e718, 10.1542/peds.2012-3584 · DOI
  23. Kirk, 2005, Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes, Ann Pharmacother, 39, 1489, 10.1345/aph.1E685 · DOI
  24. Lee, 2015, Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes, Am Heart J, 170, 760, 10.1016/j.ahj.2015.07.024 · DOI

Metadata

Authors
Shi, S., Zhou, F., & Shen, J.
Venue
Public Health
Publisher
Elsevier BV
Published
2025-02
Volume
239
Pages
94-102
ISSN
0033-3506
Cited by
5
References
8
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in the prevalence of cardiometabolic diseases in US adults with newly diagnosed and undiagnosed diabetes, 1988–2020. https://app.cochat.ai/papers/10.1016/j.puhe.2024.12.041
The paper
Shi, S., Zhou, F., & Shen, J. (2025). Trends in the prevalence of cardiometabolic diseases in US adults with newly diagnosed and undiagnosed diabetes, 1988–2020. Public Health. https://doi.org/10.1016/j.puhe.2024.12.041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.